var eventsData = [{"Ticker":"CRM","EffectiveDate":"2017-01-12","Type":"RatingNeutral","Title":"Pivotal Research downgrades CRM to Hold from Buy. Target Price is $76; previously $105.","DailyReturn":"-0.73%","FiveDayReturnAfter":"-0.26%","FiveDayReturnBefore":"3.99%"},{"Ticker":"CRM","EffectiveDate":"2016-12-19","Type":"RatingNeutral","Title":"Drexel Hamilton initiates coverage on CRM to Buy. Target Price is $100.","DailyReturn":"-0.5%","FiveDayReturnAfter":"0.01%","FiveDayReturnBefore":"-1.85%"},{"Ticker":"CRM","EffectiveDate":"2016-11-17","Type":"EarningsRevenueBeat","Title":"After market close, CRM reports 2017 Q3's earning $0.24 per share and revenue $2145MM. This beats analyst's estimated EPS $0.21, beats estimated revenue $2120MM.","DailyReturn":"2.56%","FiveDayReturnAfter":"0.86%","FiveDayReturnBefore":"-3.47%"},{"Ticker":"CRM","EffectiveDate":"2016-11-15","Type":"RatingUpgrade","Title":"OTR Global upgrades CRM to Positive from Mixed.","DailyReturn":"1.73%","FiveDayReturnAfter":"4.55%","FiveDayReturnBefore":"-4.75%"},{"Ticker":"CRM","EffectiveDate":"2016-10-18","Type":"RatingNeutral","Title":"Rosenblatt initiates coverage on CRM to Buy.","DailyReturn":"-0.08%","FiveDayReturnAfter":"3.01%","FiveDayReturnBefore":"-3.06%"},{"Ticker":"CRM","EffectiveDate":"2016-10-04","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"2.99%","FiveDayReturnAfter":"6.29%","FiveDayReturnBefore":"0.46%"},{"Ticker":"CRM","EffectiveDate":"2016-10-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.99%","FiveDayReturnAfter":"6.29%","FiveDayReturnBefore":"0.46%"},{"Ticker":"CRM","EffectiveDate":"2016-10-04","Type":"RatingNeutral","Title":"DA Davidson maintains CRM to Neutral. Target Price is $80; previously $86.","DailyReturn":"2.99%","FiveDayReturnAfter":"6.29%","FiveDayReturnBefore":"0.46%"},{"Ticker":"CRM","EffectiveDate":"2016-10-03","Type":"Item_3.02","Title":"Unregistered Sales of Equity Securities\r\n","DailyReturn":"-1.13%","FiveDayReturnAfter":"-0.59%","FiveDayReturnBefore":"1.32%"},{"Ticker":"CRM","EffectiveDate":"2016-10-03","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-1.13%","FiveDayReturnAfter":"-0.59%","FiveDayReturnBefore":"1.32%"},{"Ticker":"CRM","EffectiveDate":"2016-09-01","Type":"RatingNeutral","Title":"Morgan Stanley maintains CRM to Overweight. Target Price is $107; previously $110.","DailyReturn":"-4.41%","FiveDayReturnAfter":"-5.88%","FiveDayReturnBefore":"2.03%"},{"Ticker":"CRM","EffectiveDate":"2016-09-01","Type":"RatingNeutral","Title":"Barclays maintains CRM to Overweight. Target Price is $89.","DailyReturn":"-4.41%","FiveDayReturnAfter":"-5.88%","FiveDayReturnBefore":"2.03%"},{"Ticker":"CRM","EffectiveDate":"2016-09-01","Type":"RatingNeutral","Title":"Wunderlich maintains CRM to Buy. Target Price is $101.","DailyReturn":"-4.41%","FiveDayReturnAfter":"-5.88%","FiveDayReturnBefore":"2.03%"},{"Ticker":"CRM","EffectiveDate":"2016-09-01","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-4.41%","FiveDayReturnAfter":"-5.88%","FiveDayReturnBefore":"2.03%"},{"Ticker":"CRM","EffectiveDate":"2016-09-01","Type":"RatingNeutral","Title":"Citigroup maintains CRM to Buy. Target Price is $89; previously $94.","DailyReturn":"-4.41%","FiveDayReturnAfter":"-5.88%","FiveDayReturnBefore":"2.03%"},{"Ticker":"CRM","EffectiveDate":"2016-09-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-4.41%","FiveDayReturnAfter":"-5.88%","FiveDayReturnBefore":"2.03%"},{"Ticker":"CRM","EffectiveDate":"2016-09-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-4.41%","FiveDayReturnAfter":"-5.88%","FiveDayReturnBefore":"2.03%"},{"Ticker":"CRM","EffectiveDate":"2016-08-31","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.51%","FiveDayReturnAfter":"-6.22%","FiveDayReturnBefore":"2.29%"},{"Ticker":"CRM","EffectiveDate":"2016-08-31","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.51%","FiveDayReturnAfter":"-6.22%","FiveDayReturnBefore":"2.29%"},{"Ticker":"CRM","EffectiveDate":"2016-08-31","Type":"EarningsRevenueBeat","Title":"After market close, CRM reports 2017 Q2's earning $0.24 per share and revenue $2037MM. This beats analyst's estimated EPS $0.22, beats estimated revenue $2020MM.","DailyReturn":"-0.51%","FiveDayReturnAfter":"-6.22%","FiveDayReturnBefore":"2.29%"},{"Ticker":"CRM","EffectiveDate":"2016-08-15","Type":"RatingNeutral","Title":"OTR Global downgrades CRM to Mixed from Positive.","DailyReturn":"-3.31%","FiveDayReturnAfter":"-5.21%","FiveDayReturnBefore":"0.36%"},{"Ticker":"CRM","EffectiveDate":"2016-07-25","Type":"RatingNeutral","Title":"Morgan Stanley maintains CRM to Overweight. Target Price is $110; previously $94.","DailyReturn":"-0.43%","FiveDayReturnAfter":"-0.91%","FiveDayReturnBefore":"1.4%"},{"Ticker":"CRM","EffectiveDate":"2016-07-20","Type":"RatingNeutral","Title":"Citigroup maintains CRM to Buy. Target Price is $94; previously $97.","DailyReturn":"0.94%","FiveDayReturnAfter":"0.47%","FiveDayReturnBefore":"-0.68%"},{"Ticker":"CRM","EffectiveDate":"2016-07-07","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.33%","FiveDayReturnAfter":"3.54%","FiveDayReturnBefore":"1.21%"},{"Ticker":"CRM","EffectiveDate":"2016-07-07","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"0.33%","FiveDayReturnAfter":"3.54%","FiveDayReturnBefore":"1.21%"},{"Ticker":"CRM","EffectiveDate":"2016-07-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.33%","FiveDayReturnAfter":"3.54%","FiveDayReturnBefore":"1.21%"},{"Ticker":"CRM","EffectiveDate":"2016-07-07","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"0.33%","FiveDayReturnAfter":"3.54%","FiveDayReturnBefore":"1.21%"},{"Ticker":"CRM","EffectiveDate":"2016-07-07","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":"0.33%","FiveDayReturnAfter":"3.54%","FiveDayReturnBefore":"1.21%"},{"Ticker":"CRM","EffectiveDate":"2016-06-24","Type":"RatingNeutral","Title":"Cowen & Co. initiates coverage on CRM to Outperform.","DailyReturn":"-4.64%","FiveDayReturnAfter":"-3.55%","FiveDayReturnBefore":"0.78%"},{"Ticker":"CRM","EffectiveDate":"2016-06-14","Type":"RatingNeutral","Title":"BMO Capital initiates coverage on CRM to Outperform. Target Price is $98.","DailyReturn":"-0.49%","FiveDayReturnAfter":"-0.33%","FiveDayReturnBefore":"-1.63%"},{"Ticker":"CRM","EffectiveDate":"2016-06-02","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey maintains CRM to Buy. Target Price is $98; previously $96.","DailyReturn":"-0.25%","FiveDayReturnAfter":"-0.11%","FiveDayReturnBefore":"0.84%"},{"Ticker":"CRM","EffectiveDate":"2016-06-02","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-0.25%","FiveDayReturnAfter":"-0.11%","FiveDayReturnBefore":"0.84%"},{"Ticker":"CRM","EffectiveDate":"2016-06-02","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.25%","FiveDayReturnAfter":"-0.11%","FiveDayReturnBefore":"0.84%"},{"Ticker":"CRM","EffectiveDate":"2016-06-02","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"-0.25%","FiveDayReturnAfter":"-0.11%","FiveDayReturnBefore":"0.84%"},{"Ticker":"CRM","EffectiveDate":"2016-05-31","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.07%","FiveDayReturnAfter":"-1.12%","FiveDayReturnBefore":"3.33%"},{"Ticker":"CRM","EffectiveDate":"2016-05-31","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-0.07%","FiveDayReturnAfter":"-1.12%","FiveDayReturnBefore":"3.33%"},{"Ticker":"CRM","EffectiveDate":"2016-05-31","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.07%","FiveDayReturnAfter":"-1.12%","FiveDayReturnBefore":"3.33%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Barclays maintains CRM to Overweight. Target Price is $89; previously $88.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Brean Capital maintains CRM to Buy. Target Price is $110; previously $100.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"SunTrust Robinson Humphrey maintains CRM to Buy. Target Price is $96; previously $89.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Goldman Sachs maintains CRM to Buy. Target Price is $105; previously $99.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Credit Suisse maintains CRM to Outperform. Target Price is $115; previously $110.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Raymond James maintains CRM to Strong Buy. Target Price is $100; previously $90.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"JMP Securities maintains CRM to Market Outperform. Target Price is $92; previously $90.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"FBN Securities maintains CRM to Outperform. Target Price is $100; previously $95.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Wunderlich maintains CRM to Buy. Target Price is $101; previously $93.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"UBS maintains CRM to Buy. Target Price is $100; previously $92.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Canaccord Genuity maintains CRM to Buy. Target Price is $95; previously $88.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"JP Morgan maintains CRM to Overweight. Target Price is $95; previously $90.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"PiperJaffray maintains CRM to Overweight. Target Price is $100; previously $95.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CRM to Buy. Target Price is $93; previously $85.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Morgan Stanley maintains CRM to Overweight. Target Price is $94; previously $86.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Jefferies maintains CRM to Hold. Target Price is $80; previously $74.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"MKM Partners maintains CRM to Buy. Target Price is $96; previously $86.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Citigroup maintains CRM to Buy. Target Price is $97; previously $87.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Oppenheimer maintains CRM to Outperform. Target Price is $95; previously $88.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Deutsche Bank maintains CRM to Buy. Target Price is $95; previously $90.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Mizuho maintains CRM to Buy. Target Price is $100; previously $90.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Macquarie maintains CRM to Outperform. Target Price is $95; previously $92.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-19","Type":"RatingNeutral","Title":"Wedbush maintains CRM to Outperform. Target Price is $98; previously $95.","DailyReturn":"4.13%","FiveDayReturnAfter":"7.06%","FiveDayReturnBefore":"2.7%"},{"Ticker":"CRM","EffectiveDate":"2016-05-18","Type":"EarningsRevenueBeat","Title":"After market close, CRM reports 2017 Q1's earning $0.24 per share and revenue $1917MM. This beats analyst's estimated EPS $0.23, beats estimated revenue $1890MM.","DailyReturn":"1.43%","FiveDayReturnAfter":"7.5%","FiveDayReturnBefore":"1.11%"},{"Ticker":"CRM","EffectiveDate":"2016-05-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.43%","FiveDayReturnAfter":"7.5%","FiveDayReturnBefore":"1.11%"},{"Ticker":"CRM","EffectiveDate":"2016-05-18","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.43%","FiveDayReturnAfter":"7.5%","FiveDayReturnBefore":"1.11%"},{"Ticker":"CRM","EffectiveDate":"2016-05-12","Type":"RatingNeutral","Title":"Barclays maintains CRM to Overweight. Target Price is $88; previously $72.","DailyReturn":"0.13%","FiveDayReturnAfter":"2.7%","FiveDayReturnBefore":"2.4%"},{"Ticker":"CRM","EffectiveDate":"2016-04-26","Type":"RatingNeutral","Title":"Macquarie initiates coverage on CRM to Outperform. Target Price is $92.","DailyReturn":"-0.39%","FiveDayReturnAfter":"0.96%","FiveDayReturnBefore":"-0.98%"},{"Ticker":"CRM","EffectiveDate":"2016-04-15","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.21%","FiveDayReturnAfter":"1.3%","FiveDayReturnBefore":"1.09%"},{"Ticker":"CRM","EffectiveDate":"2016-04-01","Type":"RatingNeutral","Title":"PiperJaffray assumes CRM to Overweight.","DailyReturn":"2.57%","FiveDayReturnAfter":"1.99%","FiveDayReturnBefore":"2.81%"},{"Ticker":"CRM","EffectiveDate":"2016-03-16","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"1.43%","FiveDayReturnAfter":"1.59%","FiveDayReturnBefore":"2.65%"},{"Ticker":"CRM","EffectiveDate":"2016-03-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.43%","FiveDayReturnAfter":"1.59%","FiveDayReturnBefore":"2.65%"},{"Ticker":"CRM","EffectiveDate":"2016-03-16","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.43%","FiveDayReturnAfter":"1.59%","FiveDayReturnBefore":"2.65%"},{"Ticker":"CRM","EffectiveDate":"2016-03-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.43%","FiveDayReturnAfter":"1.59%","FiveDayReturnBefore":"2.65%"},{"Ticker":"CRM","EffectiveDate":"2016-03-04","Type":"RatingNeutral","Title":"Macquarie initiates coverage on CRM to Outperform. Target Price is $92.","DailyReturn":"0.36%","FiveDayReturnAfter":"-0.14%","FiveDayReturnBefore":"1.96%"},{"Ticker":"CRM","EffectiveDate":"2016-02-25","Type":"RatingNeutral","Title":"Barclays maintains CRM to Overweight. Target Price is $72; previously $67.","DailyReturn":"11.03%","FiveDayReturnAfter":"11.91%","FiveDayReturnBefore":"-1.53%"},{"Ticker":"CRM","EffectiveDate":"2016-02-25","Type":"RatingNeutral","Title":"Jefferies maintains CRM to Hold. Target Price is $60; previously $54.","DailyReturn":"11.03%","FiveDayReturnAfter":"11.91%","FiveDayReturnBefore":"-1.53%"},{"Ticker":"CRM","EffectiveDate":"2016-02-24","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.6%","FiveDayReturnAfter":"10.72%","FiveDayReturnBefore":"5.18%"},{"Ticker":"CRM","EffectiveDate":"2016-02-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.6%","FiveDayReturnAfter":"10.72%","FiveDayReturnBefore":"5.18%"},{"Ticker":"CRM","EffectiveDate":"2016-02-17","Type":"RatingNeutral","Title":"Credit Suisse maintains CRM to Outperform. Target Price is $100; previously $59.72.","DailyReturn":"6.31%","FiveDayReturnAfter":"5.18%","FiveDayReturnBefore":"9.97%"},{"Ticker":"CRM","EffectiveDate":"2016-02-10","Type":"RatingUpgrade","Title":"CLSA upgrades CRM to Buy from Outperform.","DailyReturn":"2.49%","FiveDayReturnAfter":"10.2%","FiveDayReturnBefore":"-11.81%"},{"Ticker":"CRM","EffectiveDate":"2016-02-10","Type":"RatingNeutral","Title":"Barclays maintains CRM to Overweight. Target Price is $67; previously $90.","DailyReturn":"2.49%","FiveDayReturnAfter":"10.2%","FiveDayReturnBefore":"-11.81%"},{"Ticker":"CRM","EffectiveDate":"2016-02-09","Type":"RatingUpgrade","Title":"Jefferies upgrades CRM to Hold.","DailyReturn":"6.06%","FiveDayReturnAfter":"9.97%","FiveDayReturnBefore":"-23.6%"},{"Ticker":"CRM","EffectiveDate":"2016-02-03","Type":"RatingNeutral","Title":"DA Davidson maintains CRM to Neutral. Target Price is $72; previously $87.","DailyReturn":"1.27%","FiveDayReturnAfter":"-11.81%","FiveDayReturnBefore":"-7.96%"},{"Ticker":"CRM","EffectiveDate":"2016-02-01","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"0.55%","FiveDayReturnAfter":"-15.11%","FiveDayReturnBefore":"-5%"},{"Ticker":"CRM","EffectiveDate":"2016-02-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.55%","FiveDayReturnAfter":"-15.11%","FiveDayReturnBefore":"-5%"},{"Ticker":"CRM","EffectiveDate":"2016-02-01","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.55%","FiveDayReturnAfter":"-15.11%","FiveDayReturnBefore":"-5%"},{"Ticker":"CRM","EffectiveDate":"2016-01-12","Type":"RatingNeutral","Title":"Brean Capital initiates coverage on CRM to Buy. Target Price is $100.","DailyReturn":"1.74%","FiveDayReturnAfter":"-3.3%","FiveDayReturnBefore":"-4.71%"},{"Ticker":"CRM","EffectiveDate":"2015-12-23","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.23%","FiveDayReturnAfter":"1.63%","FiveDayReturnBefore":"0.63%"},{"Ticker":"CRM","EffectiveDate":"2015-12-18","Type":"RatingUpgrade","Title":"Wedbush upgrades CRM to Outperform from Neutral. Target Price is $96; previously $79.","DailyReturn":"-1.78%","FiveDayReturnAfter":"-0.76%","FiveDayReturnBefore":"-1.2%"},{"Ticker":"CRM","EffectiveDate":"2015-11-19","Type":"RatingNeutral","Title":"Pacific Crest maintains CRM to Overweight. Target Price is $95; previously $80.","DailyReturn":"4.25%","FiveDayReturnAfter":"3.87%","FiveDayReturnBefore":"-1.74%"},{"Ticker":"CRM","EffectiveDate":"2015-11-19","Type":"RatingNeutral","Title":"Barclays maintains CRM to Overweight. Target Price is $90; previously $87.","DailyReturn":"4.25%","FiveDayReturnAfter":"3.87%","FiveDayReturnBefore":"-1.74%"},{"Ticker":"CRM","EffectiveDate":"2015-11-19","Type":"RatingNeutral","Title":"Bernstein maintains CRM to Underperform. Target Price is $66; previously $60.","DailyReturn":"4.25%","FiveDayReturnAfter":"3.87%","FiveDayReturnBefore":"-1.74%"},{"Ticker":"CRM","EffectiveDate":"2015-11-19","Type":"RatingNeutral","Title":"Morgan Stanley maintains CRM to Overweight. Target Price is $93; previously $85.","DailyReturn":"4.25%","FiveDayReturnAfter":"3.87%","FiveDayReturnBefore":"-1.74%"},{"Ticker":"CRM","EffectiveDate":"2015-11-18","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.14%","FiveDayReturnAfter":"3.99%","FiveDayReturnBefore":"-1.29%"},{"Ticker":"CRM","EffectiveDate":"2015-11-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.14%","FiveDayReturnAfter":"3.99%","FiveDayReturnBefore":"-1.29%"},{"Ticker":"CRM","EffectiveDate":"2015-11-16","Type":"RatingNeutral","Title":"RBC Capital maintains CRM to Outperform. Target Price is $90; previously $80.","DailyReturn":"0.87%","FiveDayReturnAfter":"6.88%","FiveDayReturnBefore":"-4.91%"},{"Ticker":"CRM","EffectiveDate":"2015-11-10","Type":"RatingNeutral","Title":"Barclays maintains CRM to Overweight. Target Price is $87; previously $80.","DailyReturn":"0.03%","FiveDayReturnAfter":"-2.53%","FiveDayReturnBefore":"-1.24%"},{"Ticker":"CRM","EffectiveDate":"2015-11-09","Type":"RatingNeutral","Title":"Lake Street initiates coverage on CRM to Buy.","DailyReturn":"-1.49%","FiveDayReturnAfter":"-4.91%","FiveDayReturnBefore":"2.16%"},{"Ticker":"CRM","EffectiveDate":"2015-09-16","Type":"RatingNeutral","Title":"Wunderlich assumes CRM to Buy. Target Price is $85.","DailyReturn":"0.85%","FiveDayReturnAfter":"0.53%","FiveDayReturnBefore":"0.71%"},{"Ticker":"CRM","EffectiveDate":"2015-09-15","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.97%","FiveDayReturnAfter":"3.16%","FiveDayReturnBefore":"4.02%"},{"Ticker":"CRM","EffectiveDate":"2015-09-15","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"1.97%","FiveDayReturnAfter":"3.16%","FiveDayReturnBefore":"4.02%"},{"Ticker":"CRM","EffectiveDate":"2015-09-10","Type":"RatingNeutral","Title":"BTIG Research initiates coverage on CRM to Buy. Target Price is $88.","DailyReturn":"1.02%","FiveDayReturnAfter":"4.04%","FiveDayReturnBefore":"3.53%"},{"Ticker":"CRM","EffectiveDate":"2015-08-28","Type":"RatingUpgrade","Title":"Exane BNP Paribas upgrades CRM to Outperform from Neutral.","DailyReturn":"0.44%","FiveDayReturnAfter":"-2.44%","FiveDayReturnBefore":"3.07%"},{"Ticker":"CRM","EffectiveDate":"2015-08-27","Type":"RatingUpgrade","Title":"Exane BNP Paribas upgrades CRM to Outperform from Neutral.","DailyReturn":"2.07%","FiveDayReturnAfter":"-0.79%","FiveDayReturnBefore":"-5%"},{"Ticker":"CRM","EffectiveDate":"2015-08-21","Type":"RatingNeutral","Title":"UBS maintains CRM to Buy. Target Price is $89; previously $85.","DailyReturn":"1.96%","FiveDayReturnAfter":"3.07%","FiveDayReturnBefore":"-5.14%"},{"Ticker":"CRM","EffectiveDate":"2015-08-21","Type":"RatingNeutral","Title":"Jefferies maintains CRM to Underperform. Target Price is $51; previously $49.","DailyReturn":"1.96%","FiveDayReturnAfter":"3.07%","FiveDayReturnBefore":"-5.14%"},{"Ticker":"CRM","EffectiveDate":"2015-08-21","Type":"RatingNeutral","Title":"Barclays maintains CRM to Overweight. Target Price is $80; previously $79.","DailyReturn":"1.96%","FiveDayReturnAfter":"3.07%","FiveDayReturnBefore":"-5.14%"},{"Ticker":"CRM","EffectiveDate":"2015-08-21","Type":"RatingUpgrade","Title":"Pivotal Research upgrades CRM to Buy from Hold. Target Price is $82; previously $79.","DailyReturn":"1.96%","FiveDayReturnAfter":"3.07%","FiveDayReturnBefore":"-5.14%"},{"Ticker":"CRM","EffectiveDate":"2015-08-21","Type":"RatingNeutral","Title":"Brean Capital maintains CRM to Buy. Target Price is $86; previously $85.","DailyReturn":"1.96%","FiveDayReturnAfter":"3.07%","FiveDayReturnBefore":"-5.14%"},{"Ticker":"CRM","EffectiveDate":"2015-08-21","Type":"RatingNeutral","Title":"JMP Securities maintains CRM to Market Outperform. Target Price is $84; previously $80.","DailyReturn":"1.96%","FiveDayReturnAfter":"3.07%","FiveDayReturnBefore":"-5.14%"},{"Ticker":"CRM","EffectiveDate":"2015-08-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-5.85%","FiveDayReturnAfter":"-5%","FiveDayReturnBefore":"1.39%"},{"Ticker":"CRM","EffectiveDate":"2015-08-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-5.85%","FiveDayReturnAfter":"-5%","FiveDayReturnBefore":"1.39%"},{"Ticker":"CRM","EffectiveDate":"2015-07-08","Type":"RatingNeutral","Title":"Northland Securities initiates coverage on CRM to Outperform. Target Price is $85.","DailyReturn":"-1.23%","FiveDayReturnAfter":"2.15%","FiveDayReturnBefore":"0.37%"},{"Ticker":"CRM","EffectiveDate":"2015-07-07","Type":"RatingUpgrade","Title":"Brean Capital upgrades CRM to Buy from Hold. Target Price is $85; previously $76.","DailyReturn":"1.59%","FiveDayReturnAfter":"2.69%","FiveDayReturnBefore":"-4.49%"},{"Ticker":"CRM","EffectiveDate":"2015-06-22","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.29%","FiveDayReturnAfter":"-3.61%","FiveDayReturnBefore":"4.4%"},{"Ticker":"CRM","EffectiveDate":"2015-06-18","Type":"RatingNeutral","Title":"Baird maintains CRM to Outperform. Target Price is $80; previously $75.","DailyReturn":"1.73%","FiveDayReturnAfter":"-1.24%","FiveDayReturnBefore":"1.88%"},{"Ticker":"CRM","EffectiveDate":"2015-06-17","Type":"RatingNeutral","Title":"Exane BNP Paribas initiates coverage on CRM to Neutral. Target Price is $81.","DailyReturn":"1.38%","FiveDayReturnAfter":"1.08%","FiveDayReturnBefore":"2.25%"},{"Ticker":"CRM","EffectiveDate":"2015-06-09","Type":"RatingNeutral","Title":"Wunderlich initiates coverage on CRM to Buy. Target Price is $85.","DailyReturn":"-0.11%","FiveDayReturnAfter":"0.99%","FiveDayReturnBefore":"-1.73%"},{"Ticker":"CRM","EffectiveDate":"2015-06-04","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.71%","FiveDayReturnAfter":"-0.6%","FiveDayReturnBefore":"-0.65%"},{"Ticker":"CRM","EffectiveDate":"2015-06-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.71%","FiveDayReturnAfter":"-0.6%","FiveDayReturnBefore":"-0.65%"},{"Ticker":"CRM","EffectiveDate":"2015-06-04","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-1.71%","FiveDayReturnAfter":"-0.6%","FiveDayReturnBefore":"-0.65%"},{"Ticker":"CRM","EffectiveDate":"2015-05-21","Type":"RatingNeutral","Title":"Deutsche Bank maintains CRM to Buy. Target Price is $90; previously $80.","DailyReturn":"3.91%","FiveDayReturnAfter":"3.52%","FiveDayReturnBefore":"-2.29%"},{"Ticker":"CRM","EffectiveDate":"2015-05-21","Type":"RatingNeutral","Title":"JP Morgan maintains CRM to Overweight. Target Price is $82; previously $78.","DailyReturn":"3.91%","FiveDayReturnAfter":"3.52%","FiveDayReturnBefore":"-2.29%"},{"Ticker":"CRM","EffectiveDate":"2015-05-21","Type":"RatingUpgrade","Title":"Argus Research upgrades CRM to Buy from Hold. Target Price is $90.","DailyReturn":"3.91%","FiveDayReturnAfter":"3.52%","FiveDayReturnBefore":"-2.29%"},{"Ticker":"CRM","EffectiveDate":"2015-05-21","Type":"RatingNeutral","Title":"Barclays maintains CRM to Overweight. Target Price is $79; previously $76.","DailyReturn":"3.91%","FiveDayReturnAfter":"3.52%","FiveDayReturnBefore":"-2.29%"},{"Ticker":"CRM","EffectiveDate":"2015-05-21","Type":"RatingNeutral","Title":"JMP Securities maintains CRM to Market Outperform. Target Price is $80; previously $75.","DailyReturn":"3.91%","FiveDayReturnAfter":"3.52%","FiveDayReturnBefore":"-2.29%"},{"Ticker":"CRM","EffectiveDate":"2015-05-21","Type":"RatingNeutral","Title":"Nomura maintains CRM to Buy. Target Price is $82; previously $80.","DailyReturn":"3.91%","FiveDayReturnAfter":"3.52%","FiveDayReturnBefore":"-2.29%"},{"Ticker":"CRM","EffectiveDate":"2015-05-21","Type":"RatingNeutral","Title":"RBC Capital maintains CRM to Outperform. Target Price is $80; previously $79.","DailyReturn":"3.91%","FiveDayReturnAfter":"3.52%","FiveDayReturnBefore":"-2.29%"},{"Ticker":"CRM","EffectiveDate":"2015-05-21","Type":"RatingNeutral","Title":"Susquehanna maintains CRM to Positive. Target Price is $85; previously $80.","DailyReturn":"3.91%","FiveDayReturnAfter":"3.52%","FiveDayReturnBefore":"-2.29%"},{"Ticker":"CRM","EffectiveDate":"2015-05-21","Type":"RatingNeutral","Title":"FBR Capital maintains CRM to Outperform. Target Price is $82; previously $78.","DailyReturn":"3.91%","FiveDayReturnAfter":"3.52%","FiveDayReturnBefore":"-2.29%"},{"Ticker":"CRM","EffectiveDate":"2015-05-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.84%","FiveDayReturnAfter":"3.39%","FiveDayReturnBefore":"-0.4%"},{"Ticker":"CRM","EffectiveDate":"2015-05-20","Type":"EarningsRevenueBeat","Title":"After market close, CRM reports 2016 Q1's earning $0.16 per share and revenue $1511MM. This beats analyst's estimated EPS $0.14, beats estimated revenue $1500MM.","DailyReturn":"-1.84%","FiveDayReturnAfter":"3.39%","FiveDayReturnBefore":"-0.4%"},{"Ticker":"CRM","EffectiveDate":"2015-05-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.84%","FiveDayReturnAfter":"3.39%","FiveDayReturnBefore":"-0.4%"},{"Ticker":"CRM","EffectiveDate":"2015-05-01","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CRM to Buy. Target Price is $83; previously $79.","DailyReturn":"0.74%","FiveDayReturnAfter":"2.3%","FiveDayReturnBefore":"6.15%"},{"Ticker":"CRM","EffectiveDate":"2015-04-30","Type":"RatingNeutral","Title":"CLSA downgrades CRM to Outperform from Buy.","DailyReturn":"-2.45%","FiveDayReturnAfter":"-1.15%","FiveDayReturnBefore":"9.75%"},{"Ticker":"CRM","EffectiveDate":"2015-03-31","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.05%","FiveDayReturnAfter":"1.99%","FiveDayReturnBefore":"-1.2%"},{"Ticker":"CRM","EffectiveDate":"2015-03-17","Type":"RatingNeutral","Title":"Brean Capital initiates coverage on CRM to Hold. Target Price is $70.","DailyReturn":"1.68%","FiveDayReturnAfter":"1.83%","FiveDayReturnBefore":"1.44%"},{"Ticker":"CRM","EffectiveDate":"2015-03-02","Type":"RatingNeutral","Title":"Argus Research downgrades CRM to Hold from Buy.","DailyReturn":"-1.32%","FiveDayReturnAfter":"-7.2%","FiveDayReturnBefore":"8.47%"},{"Ticker":"CRM","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"Jefferies maintains CRM to Underperform. Target Price is $49; previously $47.","DailyReturn":"11.72%","FiveDayReturnAfter":"3.14%","FiveDayReturnBefore":"-0.2%"},{"Ticker":"CRM","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"Deutsche Bank maintains CRM to Buy. Target Price is $80; previously $70.","DailyReturn":"11.72%","FiveDayReturnAfter":"3.14%","FiveDayReturnBefore":"-0.2%"},{"Ticker":"CRM","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"Citigroup maintains CRM to Buy. Target Price is $78; previously $71.","DailyReturn":"11.72%","FiveDayReturnAfter":"3.14%","FiveDayReturnBefore":"-0.2%"},{"Ticker":"CRM","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CRM to Buy. Target Price is $79; previously $70.","DailyReturn":"11.72%","FiveDayReturnAfter":"3.14%","FiveDayReturnBefore":"-0.2%"},{"Ticker":"CRM","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"Nomura maintains CRM to Buy. Target Price is $80; previously $70.","DailyReturn":"11.72%","FiveDayReturnAfter":"3.14%","FiveDayReturnBefore":"-0.2%"},{"Ticker":"CRM","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"JP Morgan maintains CRM to Overweight. Target Price is $78; previously $74.","DailyReturn":"11.72%","FiveDayReturnAfter":"3.14%","FiveDayReturnBefore":"-0.2%"},{"Ticker":"CRM","EffectiveDate":"2015-02-25","Type":"EarningsRelease","Title":"After market close, CRM reports 2015 Q4's earning $0.14 per share and revenue $1445MM. This meets analyst's estimated EPS $0.14, beats estimated revenue $1440MM.","DailyReturn":"1.51%","FiveDayReturnAfter":"7.79%","FiveDayReturnBefore":"-0.22%"},{"Ticker":"CRM","EffectiveDate":"2015-02-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.51%","FiveDayReturnAfter":"7.79%","FiveDayReturnBefore":"-0.22%"},{"Ticker":"CRM","EffectiveDate":"2015-02-25","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.51%","FiveDayReturnAfter":"7.79%","FiveDayReturnBefore":"-0.22%"},{"Ticker":"CRM","EffectiveDate":"2015-01-05","Type":"RatingNeutral","Title":"Mizuho initiates coverage on CRM to Buy. Target Price is $70.","DailyReturn":"-1.8%","FiveDayReturnAfter":"-1.83%","FiveDayReturnBefore":"-1.82%"},{"Ticker":"CRM","EffectiveDate":"2014-12-23","Type":"RatingNeutral","Title":"Drexel Hamilton initiates coverage on CRM to Hold.","DailyReturn":"1.06%","FiveDayReturnAfter":"-0.72%","FiveDayReturnBefore":"7.72%"},{"Ticker":"CRM","EffectiveDate":"2014-12-19","Type":"RatingNeutral","Title":"Jefferies maintains CRM to Underperform. Target Price is $47; previously $48.","DailyReturn":"0.89%","FiveDayReturnAfter":"2.44%","FiveDayReturnBefore":"6.7%"},{"Ticker":"CRM","EffectiveDate":"2014-12-17","Type":"Item_3.02","Title":"Unregistered Sales of Equity Securities\r\n","DailyReturn":"5.96%","FiveDayReturnAfter":"11.75%","FiveDayReturnBefore":"-4.27%"},{"Ticker":"CRM","EffectiveDate":"2014-12-17","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"5.96%","FiveDayReturnAfter":"11.75%","FiveDayReturnBefore":"-4.27%"},{"Ticker":"CRM","EffectiveDate":"2014-12-17","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"5.96%","FiveDayReturnAfter":"11.75%","FiveDayReturnBefore":"-4.27%"},{"Ticker":"CRM","EffectiveDate":"2014-12-12","Type":"RatingNeutral","Title":"PiperJaffray assumes CRM to Overweight. Target Price is $64.","DailyReturn":"-0.73%","FiveDayReturnAfter":"6.7%","FiveDayReturnBefore":"-6.06%"},{"Ticker":"CRM","EffectiveDate":"2014-12-05","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.16%","FiveDayReturnAfter":"-6.06%","FiveDayReturnBefore":"-0.47%"},{"Ticker":"CRM","EffectiveDate":"2014-12-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.16%","FiveDayReturnAfter":"-6.06%","FiveDayReturnBefore":"-0.47%"},{"Ticker":"CRM","EffectiveDate":"2014-11-21","Type":"RatingNeutral","Title":"Jefferies initiates coverage on CRM to Underperform. Target Price is $48.","DailyReturn":"-0.18%","FiveDayReturnAfter":"2.65%","FiveDayReturnBefore":"-8%"},{"Ticker":"CRM","EffectiveDate":"2014-11-21","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.18%","FiveDayReturnAfter":"2.65%","FiveDayReturnBefore":"-8%"},{"Ticker":"CRM","EffectiveDate":"2014-11-19","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-2.32%","FiveDayReturnAfter":"-5.14%","FiveDayReturnBefore":"-2.51%"},{"Ticker":"CRM","EffectiveDate":"2014-11-19","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.32%","FiveDayReturnAfter":"-5.14%","FiveDayReturnBefore":"-2.51%"},{"Ticker":"CRM","EffectiveDate":"2014-11-17","Type":"RatingNeutral","Title":"DA Davidson maintains CRM to Neutral. Target Price is $65; previously $60.","DailyReturn":"-2.19%","FiveDayReturnAfter":"-9.37%","FiveDayReturnBefore":"-0.09%"},{"Ticker":"CRM","EffectiveDate":"2014-11-17","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-2.19%","FiveDayReturnAfter":"-9.37%","FiveDayReturnBefore":"-0.09%"},{"Ticker":"CRM","EffectiveDate":"2014-11-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.75%","FiveDayReturnAfter":"-0.09%","FiveDayReturnBefore":"-0.03%"},{"Ticker":"CRM","EffectiveDate":"2014-11-10","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.75%","FiveDayReturnAfter":"-0.09%","FiveDayReturnBefore":"-0.03%"},{"Ticker":"CRM","EffectiveDate":"2014-11-10","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"0.75%","FiveDayReturnAfter":"-0.09%","FiveDayReturnBefore":"-0.03%"},{"Ticker":"CRM","EffectiveDate":"2014-10-16","Type":"RatingNeutral","Title":"DA Davidson maintains CRM to Neutral. Target Price is $60; previously $62.","DailyReturn":"1.46%","FiveDayReturnAfter":"5.78%","FiveDayReturnBefore":"-8.67%"},{"Ticker":"CRM","EffectiveDate":"2014-10-13","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-2.81%","FiveDayReturnAfter":"1.55%","FiveDayReturnBefore":"-6.52%"},{"Ticker":"CRM","EffectiveDate":"2014-10-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.81%","FiveDayReturnAfter":"1.55%","FiveDayReturnBefore":"-6.52%"},{"Ticker":"CRM","EffectiveDate":"2014-10-10","Type":"RatingNeutral","Title":"Nomura maintains CRM to Buy. Target Price is $70; previously $65.","DailyReturn":"-4.13%","FiveDayReturnAfter":"-5.87%","FiveDayReturnBefore":"0.86%"},{"Ticker":"CRM","EffectiveDate":"2014-10-10","Type":"RatingNeutral","Title":"Northland Securities maintains CRM to Buy. Target Price is $70; previously $65.","DailyReturn":"-4.13%","FiveDayReturnAfter":"-5.87%","FiveDayReturnBefore":"0.86%"},{"Ticker":"CRM","EffectiveDate":"2014-10-06","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"-0.27%","FiveDayReturnAfter":"-6.52%","FiveDayReturnBefore":"3.3%"},{"Ticker":"CRM","EffectiveDate":"2014-10-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.27%","FiveDayReturnAfter":"-6.52%","FiveDayReturnBefore":"3.3%"},{"Ticker":"CRM","EffectiveDate":"2014-10-06","Type":"Item_1.02","Title":"Termination of a Material Definitive Agreement\r\n","DailyReturn":"-0.27%","FiveDayReturnAfter":"-6.52%","FiveDayReturnBefore":"3.3%"},{"Ticker":"CRM","EffectiveDate":"2014-10-06","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-0.27%","FiveDayReturnAfter":"-6.52%","FiveDayReturnBefore":"3.3%"},{"Ticker":"CRM","EffectiveDate":"2014-10-03","Type":"RatingNeutral","Title":"Sterne Agee initiates coverage on CRM to Buy. Target Price is $70.","DailyReturn":"3.21%","FiveDayReturnAfter":"0.86%","FiveDayReturnBefore":"1.27%"},{"Ticker":"CRM","EffectiveDate":"2014-10-03","Type":"RatingNeutral","Title":"Societe Generale initiates coverage on CRM to Buy. Target Price is $74.","DailyReturn":"3.21%","FiveDayReturnAfter":"0.86%","FiveDayReturnBefore":"1.27%"},{"Ticker":"CRM","EffectiveDate":"2014-10-02","Type":"RatingNeutral","Title":"D.A. Davidson initiates coverage on CRM to Neutral. Target Price is $62.","DailyReturn":"-0.15%","FiveDayReturnAfter":"2.04%","FiveDayReturnBefore":"-1.62%"},{"Ticker":"CRM","EffectiveDate":"2014-09-09","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.15%","FiveDayReturnAfter":"-4.73%","FiveDayReturnBefore":"2.12%"},{"Ticker":"CRM","EffectiveDate":"2014-09-04","Type":"RatingNeutral","Title":"Barclays maintains CRM to Overweight. Target Price is $67; previously $63.","DailyReturn":"0.08%","FiveDayReturnAfter":"2.78%","FiveDayReturnBefore":"-1.02%"},{"Ticker":"CRM","EffectiveDate":"2014-08-22","Type":"RatingNeutral","Title":"UBS maintains CRM to Buy. Target Price is $76; previously $73.","DailyReturn":"7.34%","FiveDayReturnAfter":"4.52%","FiveDayReturnBefore":"4.02%"},{"Ticker":"CRM","EffectiveDate":"2014-08-22","Type":"RatingNeutral","Title":"Deutsche Bank maintains CRM to Buy. Target Price is $70; previously $65.","DailyReturn":"7.34%","FiveDayReturnAfter":"4.52%","FiveDayReturnBefore":"4.02%"},{"Ticker":"CRM","EffectiveDate":"2014-08-21","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"0.57%","FiveDayReturnAfter":"7.29%","FiveDayReturnBefore":"4.75%"},{"Ticker":"CRM","EffectiveDate":"2014-08-21","Type":"EarningsRevenueBeat","Title":"After market close, CRM reports 2015 Q2's earning $0.13 per share and revenue $1320MM. This beats analyst's estimated EPS $0.12, beats estimated revenue $1290MM.","DailyReturn":"0.57%","FiveDayReturnAfter":"7.29%","FiveDayReturnBefore":"4.75%"},{"Ticker":"CRM","EffectiveDate":"2014-08-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.57%","FiveDayReturnAfter":"7.29%","FiveDayReturnBefore":"4.75%"},{"Ticker":"CRM","EffectiveDate":"2014-07-10","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-0.54%","FiveDayReturnAfter":"-1.19%","FiveDayReturnBefore":"-8.08%"},{"Ticker":"CRM","EffectiveDate":"2014-07-10","Type":"Item_3.02","Title":"Unregistered Sales of Equity Securities\r\n","DailyReturn":"-0.54%","FiveDayReturnAfter":"-1.19%","FiveDayReturnBefore":"-8.08%"},{"Ticker":"CRM","EffectiveDate":"2014-07-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.54%","FiveDayReturnAfter":"-1.19%","FiveDayReturnBefore":"-8.08%"},{"Ticker":"CRM","EffectiveDate":"2014-07-10","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-0.54%","FiveDayReturnAfter":"-1.19%","FiveDayReturnBefore":"-8.08%"},{"Ticker":"CRM","EffectiveDate":"2014-06-30","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.21%","FiveDayReturnAfter":"-0.06%","FiveDayReturnBefore":"-0.22%"},{"Ticker":"CRM","EffectiveDate":"2014-06-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.21%","FiveDayReturnAfter":"-0.06%","FiveDayReturnBefore":"-0.22%"},{"Ticker":"CRM","EffectiveDate":"2014-06-02","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-0.47%","FiveDayReturnAfter":"-1.58%","FiveDayReturnBefore":"-1.2%"},{"Ticker":"CRM","EffectiveDate":"2014-05-21","Type":"RatingNeutral","Title":"Canaccord Genuity maintains CRM to Buy. Target Price is $65; previously $80.","DailyReturn":"-5.1%","FiveDayReturnAfter":"0.84%","FiveDayReturnBefore":"1.16%"},{"Ticker":"CRM","EffectiveDate":"2014-05-21","Type":"RatingNeutral","Title":"Citigroup maintains CRM to Buy. Target Price is $71; previously $81.","DailyReturn":"-5.1%","FiveDayReturnAfter":"0.84%","FiveDayReturnBefore":"1.16%"},{"Ticker":"CRM","EffectiveDate":"2014-05-21","Type":"RatingNeutral","Title":"Barclays maintains CRM to Overweight. Target Price is $63; previously $69.","DailyReturn":"-5.1%","FiveDayReturnAfter":"0.84%","FiveDayReturnBefore":"1.16%"},{"Ticker":"CRM","EffectiveDate":"2014-05-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.63%","FiveDayReturnAfter":"2.1%","FiveDayReturnBefore":"-0.37%"},{"Ticker":"CRM","EffectiveDate":"2014-05-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.63%","FiveDayReturnAfter":"2.1%","FiveDayReturnBefore":"-0.37%"},{"Ticker":"CRM","EffectiveDate":"2014-05-16","Type":"RatingNeutral","Title":"B. Riley maintains CRM to Neutral. Target Price is $55; previously $65.","DailyReturn":"0.73%","FiveDayReturnAfter":"3.53%","FiveDayReturnBefore":"2.5%"},{"Ticker":"CRM","EffectiveDate":"2014-05-05","Type":"RatingUpgrade","Title":"Deutsche Bank upgrades CRM to Buy from Hold. Target Price is $65; previously $65.","DailyReturn":"2.3%","FiveDayReturnAfter":"-4.2%","FiveDayReturnBefore":"-0.68%"},{"Ticker":"CRM","EffectiveDate":"2014-04-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-4.21%","FiveDayReturnAfter":"-1.71%","FiveDayReturnBefore":"-2.08%"},{"Ticker":"CRM","EffectiveDate":"2014-04-10","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-4.21%","FiveDayReturnAfter":"-1.71%","FiveDayReturnBefore":"-2.08%"},{"Ticker":"CRM","EffectiveDate":"2014-04-10","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"-4.21%","FiveDayReturnAfter":"-1.71%","FiveDayReturnBefore":"-2.08%"},{"Ticker":"CRM","EffectiveDate":"2014-03-31","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"2.4%","FiveDayReturnAfter":"-2.43%","FiveDayReturnBefore":"-2.27%"},{"Ticker":"CRM","EffectiveDate":"2014-03-13","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-3.99%","FiveDayReturnAfter":"-5.15%","FiveDayReturnBefore":"-3.45%"},{"Ticker":"CRM","EffectiveDate":"2014-03-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-3.99%","FiveDayReturnAfter":"-5.15%","FiveDayReturnBefore":"-3.45%"},{"Ticker":"CRM","EffectiveDate":"2014-03-07","Type":"RatingNeutral","Title":"B. Riley initiates coverage on CRM to Neutral. Target Price is $65.","DailyReturn":"-3.8%","FiveDayReturnAfter":"-6.67%","FiveDayReturnBefore":"-4.76%"},{"Ticker":"CRM","EffectiveDate":"2014-02-28","Type":"RatingNeutral","Title":"Bank of America maintains CRM to Buy. Target Price is $73; previously $68.","DailyReturn":"-5.81%","FiveDayReturnAfter":"-4.76%","FiveDayReturnBefore":"4.96%"},{"Ticker":"CRM","EffectiveDate":"2014-02-28","Type":"RatingNeutral","Title":"Morgan Stanley maintains CRM to Overweight. Target Price is $79; previously $72.","DailyReturn":"-5.81%","FiveDayReturnAfter":"-4.76%","FiveDayReturnBefore":"4.96%"},{"Ticker":"CRM","EffectiveDate":"2014-02-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"3.89%","FiveDayReturnAfter":"-0.09%","FiveDayReturnBefore":"1.13%"},{"Ticker":"CRM","EffectiveDate":"2014-02-27","Type":"EarningsRevenueBeat","Title":"After market close, CRM reports 2014 Q4's earning $0.07 per share and revenue $1150MM. This beats analyst's estimated EPS $0.06, beats estimated revenue $1130MM.","DailyReturn":"3.89%","FiveDayReturnAfter":"-0.09%","FiveDayReturnBefore":"1.13%"},{"Ticker":"CRM","EffectiveDate":"2014-02-27","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"3.89%","FiveDayReturnAfter":"-0.09%","FiveDayReturnBefore":"1.13%"},{"Ticker":"CRM","EffectiveDate":"2014-02-26","Type":"RatingNeutral","Title":"Barrington Research maintains CRM to Outperform. Target Price is $70; previously $62.","DailyReturn":"0.12%","FiveDayReturnAfter":"-0.93%","FiveDayReturnBefore":"-0.11%"},{"Ticker":"CRM","EffectiveDate":"2014-02-26","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CRM to Buy. Target Price is $70; previously $65.","DailyReturn":"0.12%","FiveDayReturnAfter":"-0.93%","FiveDayReturnBefore":"-0.11%"},{"Ticker":"CRM","EffectiveDate":"2014-02-24","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.5%","FiveDayReturnAfter":"-1.93%","FiveDayReturnBefore":"0.72%"},{"Ticker":"CRM","EffectiveDate":"2014-02-20","Type":"RatingNeutral","Title":"Bank of America maintains CRM to Buy. Target Price is $68; previously $64.","DailyReturn":"-0.01%","FiveDayReturnAfter":"1.13%","FiveDayReturnBefore":"2.88%"},{"Ticker":"CRM","EffectiveDate":"2014-01-31","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.72%","FiveDayReturnAfter":"1.19%","FiveDayReturnBefore":"1.47%"},{"Ticker":"CRM","EffectiveDate":"2014-01-23","Type":"RatingNeutral","Title":"Deutsche Bank downgrades CRM to Hold from Buy.","DailyReturn":"-1.73%","FiveDayReturnAfter":"-5.34%","FiveDayReturnBefore":"6.12%"},{"Ticker":"CRM","EffectiveDate":"2013-12-23","Type":"RatingNeutral","Title":"BMO Capital initiates coverage on CRM to Outperform. Target Price is $62.","DailyReturn":"1.6%","FiveDayReturnAfter":"2.66%","FiveDayReturnBefore":"4.94%"},{"Ticker":"CRM","EffectiveDate":"2013-12-06","Type":"RatingNeutral","Title":"Pivotal Research initiates coverage on CRM to Buy. Target Price is $66.","DailyReturn":"1.56%","FiveDayReturnAfter":"-3.98%","FiveDayReturnBefore":"0.64%"},{"Ticker":"CRM","EffectiveDate":"2013-11-26","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-0.85%","FiveDayReturnAfter":"-2.14%","FiveDayReturnBefore":"-5.1%"},{"Ticker":"CRM","EffectiveDate":"2013-11-19","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CRM to Buy. Target Price is $65; previously $60.","DailyReturn":"-4.99%","FiveDayReturnAfter":"-5.1%","FiveDayReturnBefore":"-1.09%"},{"Ticker":"CRM","EffectiveDate":"2013-11-19","Type":"RatingNeutral","Title":"JP Morgan maintains CRM to Neutral. Target Price is $40; previously $35.","DailyReturn":"-4.99%","FiveDayReturnAfter":"-5.1%","FiveDayReturnBefore":"-1.09%"},{"Ticker":"CRM","EffectiveDate":"2013-11-19","Type":"RatingNeutral","Title":"Nomura maintains CRM to Buy. Target Price is $65; previously $50.","DailyReturn":"-4.99%","FiveDayReturnAfter":"-5.1%","FiveDayReturnBefore":"-1.09%"},{"Ticker":"CRM","EffectiveDate":"2013-11-19","Type":"RatingNeutral","Title":"UBS maintains CRM to Buy. Target Price is $66; previously $65.","DailyReturn":"-4.99%","FiveDayReturnAfter":"-5.1%","FiveDayReturnBefore":"-1.09%"},{"Ticker":"CRM","EffectiveDate":"2013-11-19","Type":"RatingNeutral","Title":"Jefferies maintains CRM to Buy. Target Price is $66; previously $57.","DailyReturn":"-4.99%","FiveDayReturnAfter":"-5.1%","FiveDayReturnBefore":"-1.09%"},{"Ticker":"CRM","EffectiveDate":"2013-11-18","Type":"EarningsRelease","Title":"After market close, CRM reports 2014 Q3's earning $0.09 per share and revenue $1080MM. This meets analyst's estimated EPS $0.09, beats estimated revenue $1050MM.","DailyReturn":"-3.14%","FiveDayReturnAfter":"-4.67%","FiveDayReturnBefore":"3.22%"},{"Ticker":"CRM","EffectiveDate":"2013-11-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-3.14%","FiveDayReturnAfter":"-4.67%","FiveDayReturnBefore":"3.22%"},{"Ticker":"CRM","EffectiveDate":"2013-11-18","Type":"RatingNeutral","Title":"Deutsche Bank maintains CRM to Buy. Target Price is $65; previously $58.","DailyReturn":"-3.14%","FiveDayReturnAfter":"-4.67%","FiveDayReturnBefore":"3.22%"},{"Ticker":"CRM","EffectiveDate":"2013-11-18","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-3.14%","FiveDayReturnAfter":"-4.67%","FiveDayReturnBefore":"3.22%"},{"Ticker":"CRM","EffectiveDate":"2013-11-07","Type":"RatingNeutral","Title":"Morgan Stanley maintains CRM to Overweight. Target Price is $68; previously $56.","DailyReturn":"-1.59%","FiveDayReturnAfter":"3.52%","FiveDayReturnBefore":"4.51%"},{"Ticker":"CRM","EffectiveDate":"2013-11-04","Type":"RatingUpgrade","Title":"Atlantic Equities upgrades CRM to Overweight from Neutral.","DailyReturn":"3%","FiveDayReturnAfter":"2.79%","FiveDayReturnBefore":"-1.1%"},{"Ticker":"CRM","EffectiveDate":"2013-10-22","Type":"RatingNeutral","Title":"Janney Capital initiates coverage on CRM to Neutral. Target Price is $57.","DailyReturn":"-1.48%","FiveDayReturnAfter":"-2.96%","FiveDayReturnBefore":"7.39%"},{"Ticker":"CRM","EffectiveDate":"2013-10-21","Type":"RatingUpgrade","Title":"Raymond James upgrades CRM to Strong Buy from Outperform. Target Price is $64; previously $55.","DailyReturn":"1.84%","FiveDayReturnAfter":"0.84%","FiveDayReturnBefore":"5.76%"},{"Ticker":"CRM","EffectiveDate":"2013-10-17","Type":"RatingNeutral","Title":"Argus Capital initiates coverage on CRM to Buy. Target Price is $63.","DailyReturn":"0.81%","FiveDayReturnAfter":"1.43%","FiveDayReturnBefore":"5.21%"},{"Ticker":"CRM","EffectiveDate":"2013-09-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.66%","FiveDayReturnAfter":"0.91%","FiveDayReturnBefore":"0.14%"},{"Ticker":"CRM","EffectiveDate":"2013-09-10","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"1.66%","FiveDayReturnAfter":"0.91%","FiveDayReturnBefore":"0.14%"},{"Ticker":"CRM","EffectiveDate":"2013-08-30","Type":"RatingNeutral","Title":"Nomura maintains CRM to Buy. Target Price is $50; previously $48.75.","DailyReturn":"12.55%","FiveDayReturnAfter":"10.47%","FiveDayReturnBefore":"-0.22%"},{"Ticker":"CRM","EffectiveDate":"2013-08-30","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CRM to Buy. Target Price is $60; previously $53.","DailyReturn":"12.55%","FiveDayReturnAfter":"10.47%","FiveDayReturnBefore":"-0.22%"},{"Ticker":"CRM","EffectiveDate":"2013-08-29","Type":"EarningsRevenueBeat","Title":"After market close, CRM reports 2014 Q2's earning $0.09 per share and revenue $957MM. This beats analyst's estimated EPS $0.07, beats estimated revenue $938.81MM.","DailyReturn":"2.03%","FiveDayReturnAfter":"12.75%","FiveDayReturnBefore":"-1.66%"},{"Ticker":"CRM","EffectiveDate":"2013-08-29","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.03%","FiveDayReturnAfter":"12.75%","FiveDayReturnBefore":"-1.66%"},{"Ticker":"CRM","EffectiveDate":"2013-08-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.03%","FiveDayReturnAfter":"12.75%","FiveDayReturnBefore":"-1.66%"},{"Ticker":"CRM","EffectiveDate":"2013-08-20","Type":"RatingNeutral","Title":"First Analysis initiates coverage on CRM to Overweight. Target Price is $55.","DailyReturn":"-0.11%","FiveDayReturnAfter":"-0.09%","FiveDayReturnBefore":"-4.39%"},{"Ticker":"CRM","EffectiveDate":"2013-08-16","Type":"RatingUpgrade","Title":"Global Equities Research upgrades CRM to Overweight.","DailyReturn":"0.52%","FiveDayReturnAfter":"0.34%","FiveDayReturnBefore":"-3.69%"},{"Ticker":"CRM","EffectiveDate":"2013-07-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"4.47%","FiveDayReturnAfter":"7.2%","FiveDayReturnBefore":"4.03%"},{"Ticker":"CRM","EffectiveDate":"2013-07-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"4.47%","FiveDayReturnAfter":"7.2%","FiveDayReturnBefore":"4.03%"},{"Ticker":"CRM","EffectiveDate":"2013-07-11","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"4.47%","FiveDayReturnAfter":"7.2%","FiveDayReturnBefore":"4.03%"},{"Ticker":"CRM","EffectiveDate":"2013-07-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"4.47%","FiveDayReturnAfter":"7.2%","FiveDayReturnBefore":"4.03%"},{"Ticker":"CRM","EffectiveDate":"2013-07-11","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"4.47%","FiveDayReturnAfter":"7.2%","FiveDayReturnBefore":"4.03%"},{"Ticker":"CRM","EffectiveDate":"2013-07-11","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"4.47%","FiveDayReturnAfter":"7.2%","FiveDayReturnBefore":"4.03%"},{"Ticker":"CRM","EffectiveDate":"2013-07-11","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":"4.47%","FiveDayReturnAfter":"7.2%","FiveDayReturnBefore":"4.03%"},{"Ticker":"CRM","EffectiveDate":"2013-06-10","Type":"RatingNeutral","Title":"Wunderlich maintains CRM to Buy. Target Price is $65; previously $51.75.","DailyReturn":"-2.34%","FiveDayReturnAfter":"-5.31%","FiveDayReturnBefore":"-6.64%"},{"Ticker":"CRM","EffectiveDate":"2013-06-06","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"0.28%","FiveDayReturnAfter":"-0.97%","FiveDayReturnBefore":"-9.97%"},{"Ticker":"CRM","EffectiveDate":"2013-06-06","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.28%","FiveDayReturnAfter":"-0.97%","FiveDayReturnBefore":"-9.97%"},{"Ticker":"CRM","EffectiveDate":"2013-06-06","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"0.28%","FiveDayReturnAfter":"-0.97%","FiveDayReturnBefore":"-9.97%"},{"Ticker":"CRM","EffectiveDate":"2013-06-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.28%","FiveDayReturnAfter":"-0.97%","FiveDayReturnBefore":"-9.97%"},{"Ticker":"CRM","EffectiveDate":"2013-06-03","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-3.04%","FiveDayReturnAfter":"-6.64%","FiveDayReturnBefore":"-7.63%"},{"Ticker":"CRM","EffectiveDate":"2013-06-03","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"-3.04%","FiveDayReturnAfter":"-6.64%","FiveDayReturnBefore":"-7.63%"},{"Ticker":"CRM","EffectiveDate":"2013-06-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-3.04%","FiveDayReturnAfter":"-6.64%","FiveDayReturnBefore":"-7.63%"},{"Ticker":"CRM","EffectiveDate":"2013-05-24","Type":"RatingNeutral","Title":"FBN Securities maintains CRM to Outperform. Target Price is $55; previously $52.5.","DailyReturn":"-5.34%","FiveDayReturnAfter":"-7.63%","FiveDayReturnBefore":"-1%"},{"Ticker":"CRM","EffectiveDate":"2013-05-24","Type":"RatingNeutral","Title":"Wedbush downgrades CRM to Neutral from Outperform. Target Price is $42; previously $51.","DailyReturn":"-5.34%","FiveDayReturnAfter":"-7.63%","FiveDayReturnBefore":"-1%"},{"Ticker":"CRM","EffectiveDate":"2013-05-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.19%","FiveDayReturnAfter":"-6.82%","FiveDayReturnBefore":"2.18%"},{"Ticker":"CRM","EffectiveDate":"2013-05-23","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.19%","FiveDayReturnAfter":"-6.82%","FiveDayReturnBefore":"2.18%"},{"Ticker":"CRM","EffectiveDate":"2013-05-23","Type":"RevenueBeat","Title":"After market close, CRM reports 2014 Q1's earning $0.1 per share and revenue $839MM. This meets analyst's estimated EPS $0.1, misses estimated revenue $887.1MM.","DailyReturn":"-0.19%","FiveDayReturnAfter":"-6.82%","FiveDayReturnBefore":"2.18%"},{"Ticker":"CRM","EffectiveDate":"2013-04-18","Type":"Split","Title":"Stock split. After:Before = 4:1","DailyReturn":"-1.93%","FiveDayReturnAfter":"-2.24%","FiveDayReturnBefore":"-0.85%"},{"Ticker":"CRM","EffectiveDate":"2013-03-20","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"0.74%","FiveDayReturnAfter":"1.36%","FiveDayReturnBefore":"-5.43%"},{"Ticker":"CRM","EffectiveDate":"2013-03-20","Type":"RatingNeutral","Title":"FBN Securities initiates coverage on CRM to Outperform. Target Price is $210.","DailyReturn":"0.74%","FiveDayReturnAfter":"1.36%","FiveDayReturnBefore":"-5.43%"},{"Ticker":"CRM","EffectiveDate":"2013-03-20","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":"0.74%","FiveDayReturnAfter":"1.36%","FiveDayReturnBefore":"-5.43%"},{"Ticker":"CRM","EffectiveDate":"2013-03-20","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.74%","FiveDayReturnAfter":"1.36%","FiveDayReturnBefore":"-5.43%"},{"Ticker":"CRM","EffectiveDate":"2013-03-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.74%","FiveDayReturnAfter":"1.36%","FiveDayReturnBefore":"-5.43%"},{"Ticker":"CRM","EffectiveDate":"2013-03-12","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":"-2.76%","FiveDayReturnAfter":"-6.56%","FiveDayReturnBefore":"0.02%"},{"Ticker":"CRM","EffectiveDate":"2013-03-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.76%","FiveDayReturnAfter":"-6.56%","FiveDayReturnBefore":"0.02%"},{"Ticker":"CRM","EffectiveDate":"2013-03-12","Type":"Item_3.02","Title":"Unregistered Sales of Equity Securities\r\n","DailyReturn":"-2.76%","FiveDayReturnAfter":"-6.56%","FiveDayReturnBefore":"0.02%"},{"Ticker":"CRM","EffectiveDate":"2013-03-12","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-2.76%","FiveDayReturnAfter":"-6.56%","FiveDayReturnBefore":"0.02%"},{"Ticker":"CRM","EffectiveDate":"2013-03-11","Type":"RatingNeutral","Title":"Jefferies maintains CRM to Buy. Target Price is $215; previously $200.","DailyReturn":"0.04%","FiveDayReturnAfter":"-5.16%","FiveDayReturnBefore":"2.09%"},{"Ticker":"CRM","EffectiveDate":"2013-03-11","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.04%","FiveDayReturnAfter":"-5.16%","FiveDayReturnBefore":"2.09%"},{"Ticker":"CRM","EffectiveDate":"2013-03-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.04%","FiveDayReturnAfter":"-5.16%","FiveDayReturnBefore":"2.09%"},{"Ticker":"CRM","EffectiveDate":"2013-03-01","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CRM to Buy. Target Price is $210; previously $190.","DailyReturn":"7.55%","FiveDayReturnAfter":"8.62%","FiveDayReturnBefore":"0.39%"},{"Ticker":"CRM","EffectiveDate":"2013-03-01","Type":"RatingNeutral","Title":"Credit Suisse maintains CRM to Outperform. Target Price is $200; previously $185.","DailyReturn":"7.55%","FiveDayReturnAfter":"8.62%","FiveDayReturnBefore":"0.39%"},{"Ticker":"CRM","EffectiveDate":"2013-03-01","Type":"RatingNeutral","Title":"Barrington Research maintains CRM to Outperform. Target Price is $215; previously $180.","DailyReturn":"7.55%","FiveDayReturnAfter":"8.62%","FiveDayReturnBefore":"0.39%"},{"Ticker":"CRM","EffectiveDate":"2013-02-28","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"1.36%","FiveDayReturnAfter":"11.01%","FiveDayReturnBefore":"-2.44%"},{"Ticker":"CRM","EffectiveDate":"2013-02-28","Type":"EarningsRevenueBeat","Title":"After market close, CRM reports 2013 Q4's earning $0.51 per share and revenue $835MM. This beats analyst's estimated EPS $0.4, beats estimated revenue $830.63MM.","DailyReturn":"1.36%","FiveDayReturnAfter":"11.01%","FiveDayReturnBefore":"-2.44%"},{"Ticker":"CRM","EffectiveDate":"2013-02-28","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"1.36%","FiveDayReturnAfter":"11.01%","FiveDayReturnBefore":"-2.44%"},{"Ticker":"CRM","EffectiveDate":"2013-02-22","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"1.19%","FiveDayReturnAfter":"0.39%","FiveDayReturnBefore":"-2.2%"},{"Ticker":"CRM","EffectiveDate":"2013-02-11","Type":"RatingNeutral","Title":"BMO Capital maintains CRM to Outperform. Target Price is $200; previously $190.","DailyReturn":"0.4%","FiveDayReturnAfter":"2.94%","FiveDayReturnBefore":"-2.96%"},{"Ticker":"CRM","EffectiveDate":"2013-02-05","Type":"RatingNeutral","Title":"UBS maintains CRM to Buy. Target Price is $200; previously $180.","DailyReturn":"-0.2%","FiveDayReturnAfter":"-1.24%","FiveDayReturnBefore":"-3.02%"},{"Ticker":"CRM","EffectiveDate":"2013-01-30","Type":"RatingNeutral","Title":"Oppenheimer maintains CRM to Outperform. Target Price is $200; previously $180.","DailyReturn":"-1.36%","FiveDayReturnAfter":"-1.31%","FiveDayReturnBefore":"4.56%"},{"Ticker":"CRM","EffectiveDate":"2013-01-29","Type":"RatingNeutral","Title":"Maxim Group initiates coverage on CRM to Buy. Target Price is $200.","DailyReturn":"-1.89%","FiveDayReturnAfter":"-3.02%","FiveDayReturnBefore":"4.62%"},{"Ticker":"CRM","EffectiveDate":"2013-01-29","Type":"RatingNeutral","Title":"Maxim Group initiates coverage on CRM to Buy. Target Price is $200.","DailyReturn":"-1.89%","FiveDayReturnAfter":"-3.02%","FiveDayReturnBefore":"4.62%"},{"Ticker":"CRM","EffectiveDate":"2013-01-18","Type":"RatingNeutral","Title":"Jefferies maintains CRM to Buy. Target Price is $200; previously $180.","DailyReturn":"-0.64%","FiveDayReturnAfter":"1.58%","FiveDayReturnBefore":"-1.15%"},{"Ticker":"CRM","EffectiveDate":"2013-01-11","Type":"RatingNeutral","Title":"Nomura maintains CRM to Buy. Target Price is $195; previously $160.","DailyReturn":"0.13%","FiveDayReturnAfter":"-1.15%","FiveDayReturnBefore":"2.58%"},{"Ticker":"CRM","EffectiveDate":"2013-01-07","Type":"RatingNeutral","Title":"Barclays maintains CRM to Overweight. Target Price is $196; previously $169.","DailyReturn":"-0.37%","FiveDayReturnAfter":"2.18%","FiveDayReturnBefore":"2%"},{"Ticker":"CRM","EffectiveDate":"2012-12-14","Type":"RatingNeutral","Title":"Longbow Research initiates coverage on CRM to Neutral.","DailyReturn":"0.1%","FiveDayReturnAfter":"2.04%","FiveDayReturnBefore":"5.69%"},{"Ticker":"CRM","EffectiveDate":"2012-11-27","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-2.4%","FiveDayReturnAfter":"-1.99%","FiveDayReturnBefore":"10.46%"},{"Ticker":"CRM","EffectiveDate":"2012-11-27","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":"-2.4%","FiveDayReturnAfter":"-1.99%","FiveDayReturnBefore":"10.46%"},{"Ticker":"CRM","EffectiveDate":"2012-11-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-0.96%","FiveDayReturnAfter":"5.96%","FiveDayReturnBefore":"3.9%"},{"Ticker":"CRM","EffectiveDate":"2012-11-20","Type":"EarningsRevenueBeat","Title":"After market close, CRM reports 2013 Q3's earning $0.33 per share and revenue $788MM. This beats analyst's estimated EPS $0.32, beats estimated revenue $776.52MM.","DailyReturn":"-0.96%","FiveDayReturnAfter":"5.96%","FiveDayReturnBefore":"3.9%"},{"Ticker":"CRM","EffectiveDate":"2012-11-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-0.96%","FiveDayReturnAfter":"5.96%","FiveDayReturnBefore":"3.9%"},{"Ticker":"CRM","EffectiveDate":"2012-10-31","Type":"RatingNeutral","Title":"Barrington Research initiates coverage on CRM to Outperform. Target Price is $180.","DailyReturn":"-0.45%","FiveDayReturnAfter":"0.72%","FiveDayReturnBefore":"-1.59%"},{"Ticker":"CRM","EffectiveDate":"2012-10-19","Type":"RatingNeutral","Title":"Wedbush initiates coverage on CRM to Outperform. Target Price is $195.","DailyReturn":"-0.72%","FiveDayReturnAfter":"-3.24%","FiveDayReturnBefore":"-1.65%"},{"Ticker":"CRM","EffectiveDate":"2012-10-11","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains CRM to Buy. Target Price is $190; previously $175.","DailyReturn":"1.63%","FiveDayReturnAfter":"0.97%","FiveDayReturnBefore":"-4.47%"},{"Ticker":"CRM","EffectiveDate":"2012-09-21","Type":"RatingNeutral","Title":"Deutsche Bank maintains CRM to Buy. Target Price is $225; previously $220.","DailyReturn":"-0.52%","FiveDayReturnAfter":"-1.83%","FiveDayReturnBefore":"-0.62%"},{"Ticker":"CRM","EffectiveDate":"2012-09-20","Type":"RatingNeutral","Title":"BMO Capital maintains CRM to Outperform. Target Price is $190; previously $170.","DailyReturn":"-1.24%","FiveDayReturnAfter":"-5.89%","FiveDayReturnBefore":"3.39%"},{"Ticker":"CRM","EffectiveDate":"2012-09-20","Type":"RatingNeutral","Title":"Jefferies maintains CRM to Buy. Target Price is $180; previously $170.","DailyReturn":"-1.24%","FiveDayReturnAfter":"-5.89%","FiveDayReturnBefore":"3.39%"},{"Ticker":"CRM","EffectiveDate":"2012-08-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"0.35%","FiveDayReturnAfter":"-2.28%","FiveDayReturnBefore":"0.88%"},{"Ticker":"CRM","EffectiveDate":"2012-08-27","Type":"RatingNeutral","Title":"Wunderlich maintains CRM to Buy. Target Price is $207; previously $168.","DailyReturn":"0.35%","FiveDayReturnAfter":"-2.28%","FiveDayReturnBefore":"0.88%"},{"Ticker":"CRM","EffectiveDate":"2012-08-27","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":"0.35%","FiveDayReturnAfter":"-2.28%","FiveDayReturnBefore":"0.88%"},{"Ticker":"CRM","EffectiveDate":"2012-08-24","Type":"RatingNeutral","Title":"Deutsche Bank maintains CRM to Buy. Target Price is $220; previously $215.","DailyReturn":"1.2%","FiveDayReturnAfter":"-2.81%","FiveDayReturnBefore":"-0.12%"},{"Ticker":"CRM","EffectiveDate":"2012-08-23","Type":"EarningsRevenueBeat","Title":"After market close, CRM reports 2013 Q2's earning $0.42 per share and revenue $732MM. This beats analyst's estimated EPS $0.39, beats estimated revenue $728.32MM.","DailyReturn":"-1.24%","FiveDayReturnAfter":"-2.05%","FiveDayReturnBefore":"3.06%"},{"Ticker":"CRM","EffectiveDate":"2012-08-23","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-1.24%","FiveDayReturnAfter":"-2.05%","FiveDayReturnBefore":"3.06%"},{"Ticker":"CRM","EffectiveDate":"2012-08-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.24%","FiveDayReturnAfter":"-2.05%","FiveDayReturnBefore":"3.06%"},{"Ticker":"CRM","EffectiveDate":"2012-08-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"3.79%","FiveDayReturnAfter":"5.14%","FiveDayReturnBefore":"8.63%"},{"Ticker":"CRM","EffectiveDate":"2012-08-13","Type":"Item_3.02","Title":"Unregistered Sales of Equity Securities\r\n","DailyReturn":"3.79%","FiveDayReturnAfter":"5.14%","FiveDayReturnBefore":"8.63%"},{"Ticker":"CRM","EffectiveDate":"2012-08-13","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":"3.79%","FiveDayReturnAfter":"5.14%","FiveDayReturnBefore":"8.63%"},{"Ticker":"CRM","EffectiveDate":"2012-08-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"3.79%","FiveDayReturnAfter":"5.14%","FiveDayReturnBefore":"8.63%"},{"Ticker":"CRM","EffectiveDate":"2012-07-13","Type":"RatingNeutral","Title":"UBS maintains CRM to Buy. Target Price is $180; previously $190.","DailyReturn":"2.36%","FiveDayReturnAfter":"8.68%","FiveDayReturnBefore":"-11.03%"},{"Ticker":"CRM","EffectiveDate":"2012-07-13","Type":"RatingNeutral","Title":"ThinkEquity initiates coverage on CRM to Buy.","DailyReturn":"2.36%","FiveDayReturnAfter":"8.68%","FiveDayReturnBefore":"-11.03%"},{"Ticker":"CRM","EffectiveDate":"2012-06-07","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.03%","FiveDayReturnAfter":"-7.3%","FiveDayReturnBefore":"-2.85%"},{"Ticker":"CRM","EffectiveDate":"2012-06-07","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":"-1.03%","FiveDayReturnAfter":"-7.3%","FiveDayReturnBefore":"-2.85%"},{"Ticker":"CRM","EffectiveDate":"2012-06-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-1.03%","FiveDayReturnAfter":"-7.3%","FiveDayReturnBefore":"-2.85%"},{"Ticker":"CRM","EffectiveDate":"2012-06-07","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":"-1.03%","FiveDayReturnAfter":"-7.3%","FiveDayReturnBefore":"-2.85%"},{"Ticker":"CRM","EffectiveDate":"2012-05-29","Type":"RatingUpgrade","Title":"Oppenheimer upgrades CRM to Outperform from Perform. Target Price is $180.","DailyReturn":"-0.89%","FiveDayReturnAfter":"-11.35%","FiveDayReturnBefore":"0.97%"},{"Ticker":"CRM","EffectiveDate":"2012-05-29","Type":"RatingNeutral","Title":"Goldman Sachs maintains CRM to Buy. Target Price is $190; previously $170.","DailyReturn":"-0.89%","FiveDayReturnAfter":"-11.35%","FiveDayReturnBefore":"0.97%"},{"Ticker":"CRM","EffectiveDate":"2012-05-18","Type":"RatingNeutral","Title":"Morgan Stanley maintains CRM to Overweight. Target Price is $180; previously $165.","DailyReturn":"8.8%","FiveDayReturnAfter":"8.86%","FiveDayReturnBefore":"-1.21%"},{"Ticker":"CRM","EffectiveDate":"2012-05-18","Type":"RatingNeutral","Title":"PiperJaffray maintains CRM to Overweight. Target Price is $207; previously $206.","DailyReturn":"8.8%","FiveDayReturnAfter":"8.86%","FiveDayReturnBefore":"-1.21%"},{"Ticker":"CRM","EffectiveDate":"2012-05-18","Type":"RatingNeutral","Title":"UBS maintains CRM to Buy. Target Price is $190; previously $180.","DailyReturn":"8.8%","FiveDayReturnAfter":"8.86%","FiveDayReturnBefore":"-1.21%"},{"Ticker":"CRM","EffectiveDate":"2012-05-17","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"-2.03%","FiveDayReturnAfter":"9.77%","FiveDayReturnBefore":"-8.69%"},{"Ticker":"CRM","EffectiveDate":"2012-05-17","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"-2.03%","FiveDayReturnAfter":"9.77%","FiveDayReturnBefore":"-8.69%"},{"Ticker":"CRM","EffectiveDate":"2012-05-03","Type":"RatingUpgrade","Title":"Credit Suisse upgrades CRM to Outperform from Neutral. Target Price is $185; previously $146.","DailyReturn":"-0.89%","FiveDayReturnAfter":"-6.47%","FiveDayReturnBefore":"5.32%"},{"Ticker":"CRM","EffectiveDate":"2012-05-02","Type":"EarningsRelease","Title":"After market close, CRM reports 2013 Q1's earning $-0.04 per share and revenue $695.467MM..","DailyReturn":"1.31%","FiveDayReturnAfter":"-7.17%","FiveDayReturnBefore":"4.49%"},{"Ticker":"CRM","EffectiveDate":"2012-03-30","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"-1.21%","FiveDayReturnAfter":"0.4%","FiveDayReturnBefore":"2.3%"},{"Ticker":"CRM","EffectiveDate":"2012-03-28","Type":"RatingNeutral","Title":"Canaccord Genuity maintains CRM to Buy. Target Price is $180; previously $170.","DailyReturn":"0.36%","FiveDayReturnAfter":"3.09%","FiveDayReturnBefore":"1.64%"},{"Ticker":"CRM","EffectiveDate":"2012-02-28","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":"0.07%","FiveDayReturnAfter":"-0.88%","FiveDayReturnBefore":"10.41%"},{"Ticker":"CRM","EffectiveDate":"2012-02-24","Type":"RatingNeutral","Title":"UBS maintains CRM to Buy. Target Price is $180; previously $169.","DailyReturn":"9%","FiveDayReturnAfter":"9.55%","FiveDayReturnBefore":"0.87%"},{"Ticker":"CRM","EffectiveDate":"2012-02-24","Type":"RatingNeutral","Title":"Bank oferica maintains CRM to Buy. Target Price is $200; previously $160.","DailyReturn":"9%","FiveDayReturnAfter":"9.55%","FiveDayReturnBefore":"0.87%"},{"Ticker":"CRM","EffectiveDate":"2012-02-23","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":"2.88%","FiveDayReturnAfter":"11.13%","FiveDayReturnBefore":"-2.71%"},{"Ticker":"CRM","EffectiveDate":"2012-02-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":"2.88%","FiveDayReturnAfter":"11.13%","FiveDayReturnBefore":"-2.71%"}];